Nom du produit:2-[4-(2-{[(tert-butoxy)carbonyl]amino}ethyl)-1H-1,2,3-triazol-1-yl]acetic acid

IUPAC Name:2-[4-(2-{[(tert-butoxy)carbonyl]amino}ethyl)-1H-1,2,3-triazol-1-yl]acetic acid

CAS:2138103-08-7
Formule moléculaire:C11H18N4O4
Pureté:95%+
Numéro de catalogue:CM451825
Poids moléculaire:270.29

Unité d'emballage Stock disponible Prix($) Quantité
CM451825-250mg 3-4 Weeks ƏŁƩ
CM451825-500mg 4-5 Weeks řǭĨ
CM451825-1g 4-5 Weeks ǎĜţ

Pour une utilisation en R&D uniquement..

Formulaire de demande

   refresh    

Détails du produit

N° CAS:2138103-08-7
Formule moléculaire:C11H18N4O4
Point de fusion:-
Code SMILES:CC(C)(C)OC(=O)NCCC1=CN(CC(O)=O)N=N1
Densité:
Numéro de catalogue:CM451825
Poids moléculaire:270.29
Point d'ébullition:
N° Mdl:MFCD31559403
Stockage:

Category Infos

Triazoles
Triazole refers to a heterocyclic compound with the molecular formula C2H3N3, which has a five-membered ring consisting of two carbon atoms and three nitrogen atoms. Neurodegenerative diseases such as Alzheimer's disease and Parkinson's disease already affect many people around the world, and these numbers are increasing rapidly. Treatment for these disorders is often aimed at relieving symptoms and has no cure. Research on new molecules is underway, and heterocyclic compounds have important pharmacological implications. Triazoles and tetrazoles are emerging as new molecules in this field.

Related Products